ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

FUM Futura Medical Plc

39.70
0.80 (2.06%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.80 2.06% 39.70 39.15 39.80 39.35 38.85 39.05 315,724 16:35:17
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 3.1M -6.51M -0.0217 -18.04 117.73M
Futura Medical Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 38.90p. Over the last year, Futura Medical shares have traded in a share price range of 24.10p to 67.00p.

Futura Medical currently has 300,712,293 shares in issue. The market capitalisation of Futura Medical is £117.73 million. Futura Medical has a price to earnings ratio (PE ratio) of -18.04.

Futura Medical Share Discussion Threads

Showing 18001 to 18011 of 21550 messages
Chat Pages: Latest  730  729  728  727  726  725  724  723  722  721  720  719  Older
DateSubjectAuthorDiscuss
24/3/2023
20:51
Ah, some more deflection from LiarBO! I asked him to supply evidence that I use the name Petroc on LSE and not just Bucolic (which I've stated several times) It now appears that he's made up the whole story, as he has changed the subject since I asked for proof.
Yet more evidence that he is just a lying little stock basher who needs to be ignored. I'd say the same as I just said to Amberjudy, but I know the two faced slimy liar will complain to his mates the mods and get my post removed. (As he has done several times before, even though he constantly accuses 'rampers' of doing that).

petroc
24/3/2023
19:43
Why hasn’t Petroc mentioned what was said in the rest of the webinar? The part where the ‘experts’ said about some men that ‘Their ED, if it is such, can actually be more a loss of confidence that they will be able to perform with their partner. Each of the Profs. felt that Eroxon was a safe alternative to stimulate the younger person's confidence’What an eloquent description of a Placebo! But I thought Eroxon was supposed to stimulate their other head? LOLAs already known ‘placebo response rates tend to increase with transdermal gel’So ‘A possible interpretation of these trials’ FM57 and FM71 is that transdermal gels that are massaged in ‘act entirely by engaging placebo mechanisms’. So the research ‘provides further evidence supporting that gels like Eroxon are just be a potent placebo,https://www.appliedclinicaltrialsonline.com/view/placebo-effect-transdermal-nsaidsExperience has shown that while oral analgesic trials elicit some placebo response among subjects, placebo response rates tend to increase with transdermal gelThus, the placebo effect has become increasingly frustrating as drug companies seek to take advantage of the popularity and established safety of transdermal delivery systems.https://pubmed.ncbi.nlm.nih.gov/19758285/‘the placebo effect in RCT of iPDE5 for ED occurs at a rate as high as 50%’https://s4be.cochrane.org/blog/2014/10/13/richards-reviews-sham-devices-placebos/Recent research has shown that the placebo effect is not only similar for medical devices to medical trials; it is considerably larger, the effect of a sham device is almost three times that of an oral placebo.https://blogs.bu.edu/ellisrp/2014/09/nejm-sham-controls-in-medical-device-trials/Placebo effects are even larger with procedures than with drugs. Researchers at the Institute of Medical Psychology in Munich recently quantified that power for various types of placebo treatments in studies of migraine prophylaxis. They found that 58% of patients had a positive response to sham surgery and 38% had a positive response to sham acupuncture, while only 22% had a positive response to oral pharmacologic placebos.https://journals.sagepub.com/doi/abs/10.1177/026835559400900205?journalCode=phlaPlacebo Treatment: Don't Eat It, Rub it!indications to suggest that a topical placebo induces stronger effects than an oral one.https://www.nice.org.uk/advice/mib80One specialist commentator felt that the clinical effectiveness has not been demonstrated. The absence of an adequate placebo (an inactive topical gel) for highlighted as a limitation by 3 commentators. One commentator said that without it, the clinical effectiveness could be attributed to the placebo effect of rubbing a gel'
lbo
24/3/2023
18:43
'So back to what is relevant and can be substantiated' said LiarBO. So please tell us which thread this Petroc posted on LSE on the 13 March. If I can find him I'll openly apologise for saying you made him up. If you ignore this it will just be chalked up as another of your massive lies, pretending that I have two IDs on LSE.
petroc
24/3/2023
18:25
Hahaha! LiarBO seems to have swallowed it hook, line and sinker! Over on LSE in his guise of LiarBOoth, he once accused me of working for FUM, so I led him on! What a gullible little liar he is!

This is a post I made on LSE in Dec 21:

OMG, the breath-taking irony of Liarbooth coming out with "Futura need to distance themselves from these rampers before they create more serious reputational damage to Futura."
You just couldn't make that up, could you? Liarbooth, whose sole reason for being here is to trash Futura by using lies, distortions, false trails, and just plain rubbish to try and put off new investors across multiple platforms, is concerned that Futura might suffer reputational damage because I've skewered Liarbooth on his massive lie ABOUT VIAGRA !
Well, I'm sure Futura will take all appropriate measures to heed Liarbooth's warning and sack me immediately! Hahahaha! You sad sack, Liarbooth!

petroc
24/3/2023
18:21
Hahaha! LiarBO seems to have swallowed it hook, line and sinker! Over on LSE in his guise of LiarBOoth, he once accused me of working for FUM, so I led him on! What a gullible little liar he is!
petroc
24/3/2023
18:19
FTC And NAD Remind Industry Of Their Authority Over All Health Product Advertising



FTC shares jurisdiction with FDA over the marketing of dietary supplements, foods, drugs, medical devices, and other health-related products. Pursuant to a Memorandum of Understanding2 between the two agencies, FDA has primary responsibility over claims that appear on labeling, while FTC has primary responsibility for claims made in advertising. Both agencies require health-related marketing to be truthful and substantiated. Unlike FDA, however, FTC does not distinguish between categories of health-related products or claims in evaluating advertising claims. Rather, according to FTC, "the FTC's approach to the advertising of health-related products is the same regardless of whether, under FDA law, the product is considered a food, a supplement[,] or a drug."3 Moreover, FTC has emphasized that the Memorandum of Understanding does not "limit the FTC's jurisdiction or prohibit the agency from taking action against deceptive labeling claims or obtaining orders that address all forms of marketing, including claims that appear in labeling."4

Ensure Clear and Conspicuous Disclosure—Where disclosure of qualifying information is necessary, FTC requires such disclosure to be presented clearly and conspicuously, so "it is difficult to miss (i.e., noticeable) and easily understandable by ordinary consumers

Monitor the Quality of the Evidence—Additionally, FTC discusses that it will also examine the internal validity of each piece of evidence provided to support a health claim. FTC advises marketers to ensure the research on which they rely complies with the following basic principles:
The human clinical trial should have both a treatment group and a control group;
The study should be randomized;
The study should be double blinded;

lbo
24/3/2023
18:19
LiarBO has also made up this character on LSE called Petroc. I've never seen him over there, and he certainly hasn't posted on the FUM board.
petroc
24/3/2023
18:15
Here is some more of the multi-ID rampers false and misleading claims all over the internet and social mediaThe multi-ID rampers even falsely claimed it was a' new drug' and claiming he works for FUM. Others said they came across FUM from the multi-ID rampers using Telegram to ramp it and other admitted to using BOTS, podcasts etchttps://www.ftc.gov/news-events/news/press-releases/2008/01/appeals-court-affirms-ruling-ftcs-favor-q-ray-bracelet-caseThe court found that proof is what separates an effect new to science from a swindle and that the defendants have no proof, stating that the 'tests' the defendants relied on were 'bunk'petroc19 Mar '23 - 16:10 - 17425 of 17427Bear in mind of course that I work for FUM'https://www.cnbc.com/2022/12/14/sec-charges-social-media-influencers-in-alleged-100-million-fraud-scheme.htmlBut they did not disclose to their followers while promoting those stocks that they planned to sell shares once prices or trading volumes rose, the DOJ and SEC alleged. The influencers gained a profit by pumping the stock prices and then selling once they roseandyr42 - 23 Mar 2021 - 15:03:15 - 9033 of 17363whats the gut feel of you telegram group. Care to share pls?Billthebank - 23 Mar 2021 - 14:06:06 - 9029 of 17363TBH no I do not normally get it right but I did today thanks to a couple of people in the telegram group.Albert Arthur - 08 Dec 2021 - 14:43:19 - 10140 of 17333I did a couple of Sunday roast, I mentioned FUMhttps://www.share-talk.com/traders-cafe-with-zak-mir-sunday-roast-31st-october-2021-via-vox-markets/Zak Mir is joined by Sunday Roast regulars Albert Arthurhttps://www.jiosaavn.com/shows/29:-Traders-Cafe-with-Zak-Mir:-Sunday-Roast-June-6/kl4TsQKlN0g_Alberts week 1m 48s on Futura Medical (FUM) new drug 2m 34shttps://twitter.com/roastpr/status/1411669710257668096?s=21Albert Arthur8 Dec '21 - 11:16 - 10125 of 16732Bot streams to Twitter and TelegramAlbert Arthur - 21 Mar 2021 - 13:56:12 - 8701 of 17333I spoke with Zak about FUM Friday.https://twitter.com/freeyourmind888/status/1635627477119770624?s=21https://twitter.com/kgfb10807715/status/1635365416846659585?s=21https://twitter.com/Albert__ArthurBroomrigg - 14 Dec 2022 - 12:41:29 - 14800 of 16193Today's Trader's Cafe with Zak Mir: Bulletin Board Heroes (on Vox markets)......(Listen from 6m 5s)He's looking for 60p by the end of the month (note: this is just on chart analysis and does not take into account potential news flow re. revenues next year which will leave 60p in the dust).https://www.voxmarkets.co.uk/articles/trader-s-cafe-with-zak-mir-bulletin-board-heroes-december-14-7ca672b
lbo
24/3/2023
18:01
And as per the relevant and applicable ASA rulings have clearly said about claims that cannot be substantiated and are misleading!

‘Because the trial was not placebo-controlled’

‘There was no statistically significant difference between the outcomes for the treatment group’

concluded that the claim had not been substantiated and was misleading’


(So patients using the eroxon gel device) have never been compared to any adequate and equivalent control group (using an inactive sham device) eg arousal gel.



So FM71 ‘study was accordingly not adequate evidence of the efficacy’




Assessment

Upheld

The ASA noted that the product appeared to meet the requirements of the Medical Device Directive (MDD) but understood that the MDD did not harmonise EU law relating the advertising of medical devices, which was subject to Directive 2005/29/EC on unfair business to consumer commercial practices (including advertising) generally (Unfair commercial practices directive - UCPD). That meant that advertisers must still meet the requirements of the CAP Code, which reflected the provisions of UCPD. Under the CAP and BCAP Codes, medical claims could be made for CE-marked medical devices provided they complied with other requirements of the Codes, including those relating to substantiation.

CE certification in itself does not constitute evidence for medical efficacy claims, and advertisers need to ensure that they hold evidence for such claims.

There was no statistically significant difference between the outcomes for the treatment group (patients using the Aerosure device) and the control group (using an inactive sham device). The study was accordingly not adequate evidence of the efficacy




Because the trial was not placebo-controlled, we considered AcceleDent had not provided adequate evidence to support the claim AcceleDent, is also clinically proven to reduce the pain and discomfort associated with braces and aligners by up to 71%. We concluded that the claim had not been substantiated and was misleading.

On that point the claim breached CAP Code (Edition 12) rules 3.1 (Misleading advertising), 3.7 (Substantiation) and 12.1 Medicines, medical devices, health-related products and beauty products.



Assessment

Upheld

The ASA noted that the product appeared to meet the requirements of the Medical Device Directive (MDD) but understood that the MDD did not harmonise EU law relating the advertising of medical devices, which was subject to Directive 2005/29/EC on unfair business to consumer commercial practices (including advertising) generally (Unfair commercial practices directive - UCPD). That meant that advertisers must still meet the requirements of the CAP Code, which reflected the provisions of UCPD. Under the CAP and BCAP Codes, medical claims could be made for CE-marked medical devices provided they complied with other requirements of the Codes, including those relating to substantiation.

CE certification in itself does not constitute evidence for medical efficacy claims, and advertisers need to ensure that they hold evidence for such claims.

There was no statistically significant difference between the outcomes for the treatment group (patients using the Aerosure device) and the control group (using an inactive sham device). The study was accordingly not adequate evidence of the efficacy

lbo
24/3/2023
17:58
Actually I'm interested in this Petroc on LSE. Why not share some more info about him? Perhaps a few posts he has made. Or have you just made him up? Anyway, you seem to know a lot about the workings of LSE. Thought you'd never been there?
petroc
24/3/2023
17:43
One slimy character in particular to be vigilant of is the omnipresent stock ramper. S/he can be found on almost every discussion board / forum and too many times investors can make bad buy decisions by following the rampers misguided advice.

3. They attack those who disagree with their lofty predictions. They cannot back up their arguments with a rational discussion, so they resort to petty name calling and telling others who disagree with them that they are "full of it."
4. They are not open minded. You cannot have an intelligent discussion with these types. They will do whatever they can to discredit those who disagree with them by spreading false information. They are very often antagonistic.


So again all just false and misleading claims form the proven multi-ID ramper that cannot be substantiated with any non deficient evidence! Next he will be claiming I am the major shareholder Lombard odier as that also contains the letters l, b and o. Or hasn’t he done that already under another name and accused me of being the same name! Or what about Bucolic!? That also contains l, B and o! So many proven lies by Petroc! So he is now claiming he is only Petroc on here but not Petroc over there! But he is Bucolic! He.cant even keep up with all his lies or multi-IDs! LOL

J777J - 03 Apr 2021 - 11:00:51 - 9264 of 17653
Isnt it funny you are trying to make you are Lombard Odier with your LBO handle,which is identity theft.
You are also posting as liambooth on Lse.

petroc - 28 Feb 2023 - 11:24:16 - 16672 of 17500

I have one name here - Petroc, and Bucolic on LSE


Yet there is a Petroc also over on LSE? Another lie confirmed!

Member Info for Petroc Member Since 12th Mar 2021

Member Info for Bucolic Member Since 21st Nov 2019


petroc - 18 Mar 2023 - 16:54:59 - 17374 of 17502

LSE is the bb to visit if you want decent chat about FUM

petroc 19 Mar '23 - 16:10 - 17425 of 17427

˜Bear in mind of course that I work for FUM’

lbo
Chat Pages: Latest  730  729  728  727  726  725  724  723  722  721  720  719  Older